Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations [5]

Ludovic Lacroix; Patricia Pautier; Pierre Duvillard; Nelly Motté; Patrick Saulnier; Jean Michel Bidart; Jean Charles Soria

doi:10.1002/ijc.21460

Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations [5]

Ludovic Lacroix, Patricia Pautier, Pierre Duvillard, Nelly Motté, Patrick Saulnier, Jean Michel Bidart, Jean Charles Soria

Research output: Contribution to journal › Letter › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	1068-1069
Number of pages	2
Journal	International Journal of Cancer
Volume	118
Issue number	4
DOIs	https://doi.org/10.1002/ijc.21460
Publication status	Published - 15 Feb 2006

Access to Document

10.1002/ijc.21460

Cite this

@article{a660673772344e319bce9c07eaad24b2,

title = "Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations [5]",

author = "Ludovic Lacroix and Patricia Pautier and Pierre Duvillard and Nelly Mott{\'e} and Patrick Saulnier and Bidart, {Jean Michel} and Soria, {Jean Charles}",

year = "2006",

month = feb,

day = "15",

doi = "10.1002/ijc.21460",

language = "English",

volume = "118",

pages = "1068--1069",

journal = "International Journal of Cancer",

issn = "0020-7136",

number = "4",

}

TY - JOUR

T1 - Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations [5]

AU - Lacroix, Ludovic

AU - Pautier, Patricia

AU - Duvillard, Pierre

AU - Motté, Nelly

AU - Saulnier, Patrick

AU - Bidart, Jean Michel

AU - Soria, Jean Charles

PY - 2006/2/15

Y1 - 2006/2/15

UR - http://www.scopus.com/inward/record.url?scp=31544463584&partnerID=8YFLogxK

U2 - 10.1002/ijc.21460

DO - 10.1002/ijc.21460

M3 - Letter

C2 - 16152583

AN - SCOPUS:31544463584

SN - 0020-7136

VL - 118

SP - 1068

EP - 1069

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 4

ER -

Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations [5]

Access to Document

Other files and links

Cite this